7MW: Recovery Modeling Workshop Call for Abstracts 

Abstract submission deadline will be Jan 15, 2027.

7MW will be held in Biberach, Germany on the 10 – 13^th May 2027.

Click HERE to fill out the abstract submission form!

Continuing in the rich history of the Modeling Workshops over the past decade, the goal of the 7^th Modeling Workshop (7MW), supported by Recovery of Biological Products, is to foster exchange related to the advancement and implementation of predictive modeling in downstream process development, scale-up, manufacturing and sustainability to address key technical challenges and gaps for the benefit of the biopharma industry.  The implementation of digital and predictive modeling tools to upstream, downstream, and formulations development are in scope as defined by the organizers of each individual workshop and in accordance with specific topics critical to the biopharma industry at the time.  An example of the challenges, gaps and solutions discussed at 5MW in 2023 are presented in Wittkopp et al “Proceedings of the 5^th Modeling Workshop, Biotechnology and Bioengineering 121(9) 2952-2973, https;//doi.org/10.1002/bit.28768.  Abstracts submitted that most closely adhere to the goal of exchange and advancement of modeling as a tool to improve biologics process development and manufacturing will be those to be highly considered. 

To emphasize the goal of exchange, the conference is organized into short presentations (< 15 minutes depending on the program set-up) that are designed to initiate a discussion around the presenter’s topic, challenge or case study followed by a longer, in-depth discussion (panel with audience Q&A) around the topic presented.  For this reason, the workshop is kept small, with invitations extended mostly to those actively involved in modeling and the implementation of predictive models to drive decisions.

The 7MW will be designed to focus on the implementation of mechanistic and hybrid predictive models, the advancement of the acceptance of these models by industry leaders and regulatory authorities and the interconnectivity of models to achieve a holistic model for the prediction of process outcomes.  Successful abstracts should meet the criteria described above and may cover modeling approaches ranging from molecular dynamics to facility models.  The scope is intentionally broad and not restricted beyond predictive modeling applications in the biopharma industry. Example for topic for abstracts:

• Case studies of predictive successes or regulatory interactions
• Examples of holistic application of predictive models across different unit operations for instance; model predictive control or holistic process development
• Scientific advancements in modeling and their application to process understanding, including novel applications and emerging modalities
• Case studies on the use of different types of predictive models (multi-scale) and how decisions are made to apply or combine those models, for instance machine learning with mechanistic models
• Models from molecular dynamics to facility plant modeling including Sustainability assessments
• Modeling at DSP interfaces e.g. from cell culture, harvest, or formulation

If there are any questions, please feel free to contact any of the following planning committee members:

• Joey Studts - Boehringer Ingelheim
• Frederico Will – Boehringer Ingelheim
• Felix Wittkopp - Roche Diagnostics GmbH
• Arne Staby – Arnack Consulting ApS
• Julie Robinson – MSD
• Sofia Nunes - Lonza
• David Roush - Roush Biopharma Panacea, LLC
• Xuankuo Xu - AstraZeneca
• John Welsh - Rivanna Bioprocess Solutions LLC
• Jessica Lyall - Genentech
• Stephen Hunt, Merck & Co., Inc.
• Siddharth Parimal, GSK
• Felix Seelinger – Novartis
• Andre Dumetz - AbbVie

The Recovery of Biological Products Conference Series is the premier international forum for the presentation and discussion of recent advances in the operations used to recover biological products of therapeutic, diagnostic and industrial value to society. An invitation-only biennial event, the Conference Series provides delegates with a clear and comprehensive understanding of the status and direction of this fast-moving field.

Sponsored by the American Chemical Society, Division of Biochemical Technology (BIOT), this international conference provides exposure to the latest developments in bioprocessing with a focus on downstream processing and aspects that affect the downstream steps. Unparalleled opportunities to network with industry leaders are a key feature of the conference. The size, venue and schedule of the meeting are specifically designed to provide multiple opportunities for discussion and development of new areas and concepts relating to the separation, purification and efficient processing of biological products. The Conference Series is a Not-for-Profit 501(c) (3) organization.